Skip to main content

Table 2 Comparison between survivors and nonsurvivors

From: Relationship between hyperglycemia, hormone disturbances, and clinical evolution in severely hyperglycemic post surgery critically ill children: an observational study

 

Survivors

Nonsurvivors

P

 

Median

(IQR)

Median

(IQR)

 

Onset of hyperglycemia, h

6.5

(3.7 -27)

59

(13.5-137.5)

.028

Baseline cortisol, μg/dL

37

(12.4-66)

100

(74–138)

.024

Cortisol at 24 h, μg/dL

13

(5.6 -22.4)

39.7

(29.9-59.3)

.003

Baseline GH, μg/dL

0.7

(0.5-3.6)

15

(1.8-31)

.026

Sensitivity with C-peptide at 72 h, %

29.0

(14.3-67.8)

11.9

(10.7-12.9)

.026

IR with C-peptide at 72 h

3.4

(1.5-6.9)

8.4

(7.7 -9.3)

.026

Cardiogenic shock

7.3%

60%

.014

Nosocomial infection

30.7%

100%

.008

ECMO

0%

100%

.001

CRRT

0%

100%

.001

  1. Abbreviations: CCRT continuous renal replacement therapy, ECMO extracorporeal membrane oxygenation, GH growth hormone, IR insulin resistance, IQR interquartile range.